Literature DB >> 28905008

Probiotics as a preventive strategy for surgical infection in colorectal cancer patients: a systematic review and meta-analysis of randomized trials.

Priscilla Régia de Andrade Calaça1,2, Raquel Pedrosa Bezerra1,2, Wendell Wagner Campos Albuquerque1, Ana Lúcia Figueiredo Porto1,2,3, Maria Taciana Holanda Cavalcanti1,2.   

Abstract

BACKGROUND: Infection following abdominal surgery remains a major factor in morbidity among colorectal cancer (CRC) patients. Probiotic therapy has been suggested to improve the clinical and laboratory outcome of patients undergoing gastrointestinal surgery. The aim of this study was to investigate the efficacy of probiotic lactic acid bacteria in patients with CRC in the pre- and postoperative phases.
METHODS: Systematic database searches identified 1,080 related articles. However, only seven articles were selected according to the eligibility criteria for qualitative and quantitative evaluation.
RESULTS: Most of the reviewed articles presented satisfactory results related to the prevention of surgical inflammation in patients undergoing resection of CRC when using strains of Lactobacillus genus, predominantly.
CONCLUSIONS: Probiotics are suggested to prevent surgical inflammation of CRC, at the same time that the combination of particular microorganisms administered is beneficial to the treatment and surgical recovery.

Entities:  

Keywords:  Colorectal cancer (CRC); meta-analysis; perioperative; probiotics

Year:  2017        PMID: 28905008      PMCID: PMC5590023          DOI: 10.21037/tgh.2017.08.01

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  30 in total

1.  Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer.

Authors:  Naoya Aisu; Shu Tanimura; Yuichi Yamashita; Kanefumi Yamashita; Kenji Maki; Yoichiro Yoshida; Takamitsu Sasaki; Shinsuke Takeno; Seiichiro Hoshino
Journal:  Exp Ther Med       Date:  2015-07-15       Impact factor: 2.447

2.  Perioperative synbiotic therapy in elderly patients undergoing gastroenterological surgery: a prospective, randomized control trial.

Authors:  Mitsuyoshi Okazaki; Satoshi Matsukuma; Ryuichiro Suto; Kensuke Miyazaki; Masaaki Hidaka; Mitsutoshi Matsuo; Shinji Noshima; Nobuya Zempo; Takashi Asahara; Koji Nomoto
Journal:  Nutrition       Date:  2013-07-16       Impact factor: 4.008

3.  Use of pro-/synbiotics as prophylaxis in patients undergoing colorectal resection for cancer: a meta-analysis of randomized controlled trials.

Authors:  Dan He; Hai-Yang Wang; Jing-Yan Feng; Ming-Ming Zhang; Yong Zhou; Xiao-Ting Wu
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-11-20       Impact factor: 2.947

4.  Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial.

Authors:  Jee-Yon Lee; Sang-Hui Chu; Justin Y Jeon; Mi-Kyung Lee; Ji-Hye Park; Duk-Chul Lee; Ji-Won Lee; Nam-Kyu Kim
Journal:  Dig Liver Dis       Date:  2014-10-23       Impact factor: 4.088

5.  A comparison of trends in operative approach and postoperative outcomes for colorectal cancer surgery.

Authors:  Jamin K Addae; Faiz Gani; Sandy Y Fang; Elizabeth C Wick; Azah A Althumairi; Jonathan E Efron; Joseph K Canner; David M Euhus; Eric B Schneider
Journal:  J Surg Res       Date:  2016-09-17       Impact factor: 2.192

Review 6.  Bifidobacteria-Insight into clinical outcomes and mechanisms of its probiotic action.

Authors:  Amrita Sarkar; Santanu Mandal
Journal:  Microbiol Res       Date:  2016-07-11       Impact factor: 5.415

7.  Comparison between oral antibiotics and probiotics as bowel preparation for elective colon cancer surgery to prevent infection: prospective randomized trial.

Authors:  Sotaro Sadahiro; Toshiyuki Suzuki; Akira Tanaka; Kazutake Okada; Hiroko Kamata; Toru Ozaki; Yasuhiro Koga
Journal:  Surgery       Date:  2014-03       Impact factor: 3.982

8.  Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers.

Authors:  Francesco Russo; Michele Linsalata; Caterina Clemente; Marisa Chiloiro; Antonella Orlando; Emanuele Marconi; Guglielmina Chimienti; Giuseppe Riezzo
Journal:  Nutr Res       Date:  2012-11-17       Impact factor: 3.315

9.  A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients.

Authors:  Luca Gianotti; Lorenzo Morelli; Francesca Galbiati; Simona Rocchetti; Sara Coppola; Aldo Beneduce; Cristina Gilardini; Daniela Zonenschain; Angelo Nespoli; Marco Braga
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

10.  The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial.

Authors:  Yongzhi Yang; Yang Xia; Hongqi Chen; Leiming Hong; Junlan Feng; Jun Yang; Zhe Yang; Chenzhang Shi; Wen Wu; Renyuan Gao; Qing Wei; Huanlong Qin; Yanlei Ma
Journal:  Oncotarget       Date:  2016-02-16
View more
  8 in total

Review 1.  SSAT State-of-the-Art Conference: Advancements in the Microbiome.

Authors:  Miquell O Miller; Purna C Kashyap; Sarah L Becker; Ryan M Thomas; Richard A Hodin; George Miller; Mautin Hundeyin; Smruti Pushalkar; Deirdre Cohen; Deepak Saxena; Benjamin D Shogan; Gareth J Morris-Stiff
Journal:  J Gastrointest Surg       Date:  2021-07       Impact factor: 3.452

2.  Gut microbiota and surgical disease.

Authors:  Bengt Jeppsson
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

Review 3.  Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches.

Authors:  Priyankar Dey; Saumya Ray Chaudhuri
Journal:  Biology (Basel)       Date:  2022-05-16

Review 4.  Clinical update on head and neck cancer: molecular biology and ongoing challenges.

Authors:  Elham Alsahafi; Katheryn Begg; Ivano Amelio; Nina Raulf; Philippe Lucarelli; Thomas Sauter; Mahvash Tavassoli
Journal:  Cell Death Dis       Date:  2019-07-15       Impact factor: 8.469

5.  Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.

Authors:  Karolina Kaźmierczak-Siedlecka; Agnieszka Daca; Mateusz Fic; Thierry van de Wetering; Marcin Folwarski; Wojciech Makarewicz
Journal:  Gut Microbes       Date:  2020-05-26

6.  Analysis of abnormal intestinal flora on risk of intestinal cancer and effect of heparin on formation of bacterial biofilm.

Authors:  Qilong Chen; Lin Xu; Tinglun Wu; Jian Li; Li Hua
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 7.  Probiotics/Synbiotics to Reduce Infectious Complications after Colorectal Surgery: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Authors:  Julie Veziant; Mathilde Bonnet; Bob V Occean; Chadly Dziri; Bruno Pereira; Karem Slim
Journal:  Nutrients       Date:  2022-07-26       Impact factor: 6.706

Review 8.  The Role of Probiotics in Colorectal Cancer Management.

Authors:  Bhagavathi Sundaram Sivamaruthi; Periyanaina Kesika; Chaiyavat Chaiyasut
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-14       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.